Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan; Kaeshaelya Thiruchelvam

doi:10.1007/s40266-024-01106-z

Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	283-285
Number of pages	3
Journal	Drugs and Aging
Volume	41
Issue number	3
Early online date	28 Feb 2024
DOIs	https://doi.org/10.1007/s40266-024-01106-z
Publication status	Published - 1 Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40266-024-01106-zLicence: Unspecified

Cite this

@article{3101af3b1f634afe8bec1af5eea69c37,

title = "Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”",

keywords = "Polypharmacy, Antibody Response, SARS‑CoV‑2 Vaccination",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad} and Kaeshaelya Thiruchelvam",

year = "2024",

month = mar,

day = "1",

doi = "10.1007/s40266-024-01106-z",

language = "English",

volume = "41",

pages = "283--285",

journal = "Drugs and Aging",

issn = "1170-229X",

publisher = "Adis International Ltd",

number = "3",

}

TY - JOUR

T1 - Comment on

T2 - “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

AU - Thiruchelvam, Kaeshaelya

PY - 2024/3/1

Y1 - 2024/3/1

KW - Polypharmacy

KW - Antibody Response

KW - SARS‑CoV‑2 Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85186188827&partnerID=8YFLogxK

U2 - 10.1007/s40266-024-01106-z

DO - 10.1007/s40266-024-01106-z

M3 - Letter

AN - SCOPUS:85186188827

VL - 41

SP - 283

EP - 285

JO - Drugs and Aging

JF - Drugs and Aging

SN - 1170-229X

IS - 3

ER -

Comment on: “Polypharmacy and Antibody Response to SARS-CoV-2 Vaccination in Residents of Long-Term Care Facilities: the GeroCovid Study”

UN SDGs

Access to Document

Other files and links

Cite this